Search Page

1

Cite

Share

Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial.

Brown LK, Freemantle N, Breuer J, Dehbi HM, Chowdhury K, Jones G, Ikeji F, Ndoutoumou A, Santhirakumar K, Longley N, Checkley AM, Standing JF, Lowe DM. Brown LK, et al. Among authors: standing jf. Trials. 2021 Mar 8;22(1):193. doi: 10.1186/s13063-021-05139-2. Trials. 2021. PMID: 33685502 Free PMC article.

Cite

Share

2

Cite

Share

IV and oral fosfomycin pharmacokinetics in neonates with suspected clinical sepsis.

Kane Z, Gastine S, Obiero C, Williams P, Murunga S, Thitiri J, Ellis S, Correia E, Nyaoke B, Kipper K, van den Anker J, Sharland M, Berkley JA, Standing JF. Kane Z, et al. Among authors: standing jf. J Antimicrob Chemother. 2021 Jun 18;76(7):1855-1864. doi: 10.1093/jac/dkab083. J Antimicrob Chemother. 2021. PMID: 33855449 Free PMC article. Clinical Trial.

Cite

Share

3

Cite

Share

Pharmacokinetic studies in children: recommendations for practice and research.

Barker CIS, Standing JF, Kelly LE, Hanly Faught L, Needham AC, Rieder MJ, de Wildt SN, Offringa M. Barker CIS, et al. Among authors: standing jf. Arch Dis Child. 2018 Jul;103(7):695-702. doi: 10.1136/archdischild-2017-314506. Epub 2018 Apr 19. Arch Dis Child. 2018. PMID: 29674514 Free PMC article. Review.

Cite

Share

4

Cite

Share

Useful pharmacodynamic endpoints in children: selection, measurement, and next steps.

Kelly LE, Sinha Y, Barker CIS, Standing JF, Offringa M. Kelly LE, et al. Among authors: standing jf. Pediatr Res. 2018 Jun;83(6):1095-1103. doi: 10.1038/pr.2018.38. Epub 2018 Apr 18. Pediatr Res. 2018. PMID: 29667952 Free PMC article. Review.

Cite

Share

5

Cite

Share

Pharmacokinetics and pharmacodynamics of oseltamivir in neonates, infants and children.

Standing JF, Tsolia M, Lutsar I. Standing JF, et al. Infect Disord Drug Targets. 2013 Feb;13(1):6-14. doi: 10.2174/18715265112129990003. Infect Disord Drug Targets. 2013. PMID: 23675922 Review.

Cite

Share

6

Cite

Share

Variation in Target Attainment of Beta-Lactam Antibiotic Dosing Between International Pediatric Formularies.

Gastine S, Hsia Y, Clements M, Barker CIS, Bielicki J, Hartmann C, Sharland M, Standing JF. Gastine S, et al. Among authors: standing jf. Clin Pharmacol Ther. 2021 Apr;109(4):958-970. doi: 10.1002/cpt.2180. Epub 2021 Feb 28. Clin Pharmacol Ther. 2021. PMID: 33521971 Free PMC article. Review.

Cite

Share

7

Cite

Share

Diclofenac for acute pain in children.

Standing JF, Savage I, Pritchard D, Waddington M. Standing JF, et al. Cochrane Database Syst Rev. 2009 Oct 7;(4):CD005538. doi: 10.1002/14651858.CD005538.pub2. Cochrane Database Syst Rev. 2009. PMID: 19821348 Updated. Review.

Cite

Share

8

Cite

Share

Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunology.

Barker CI, Germovsek E, Hoare RL, Lestner JM, Lewis J, Standing JF. Barker CI, et al. Among authors: standing jf. Adv Drug Deliv Rev. 2014 Jun;73(100):127-39. doi: 10.1016/j.addr.2014.01.002. Epub 2014 Jan 17. Adv Drug Deliv Rev. 2014. PMID: 24440429 Free PMC article. Review.

Cite

Share

9

Cite

Share

The use of polymyxins to treat carbapenem resistant infections in neonates and children.

Thomas R, Velaphi S, Ellis S, Walker AS, Standing JF, Heath P, Sharland M, Dona' D. Thomas R, et al. Among authors: standing jf. Expert Opin Pharmacother. 2019 Mar;20(4):415-422. doi: 10.1080/14656566.2018.1559817. Epub 2018 Dec 21. Expert Opin Pharmacother. 2019. PMID: 30576264 Review.

Cite

Share

10

Cite

Share

Pharmacokinetic-Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance.

Germovsek E, Barker CIS, Sharland M, Standing JF. Germovsek E, et al. Among authors: standing jf. Clin Pharmacokinet. 2019 Jan;58(1):39-52. doi: 10.1007/s40262-018-0659-0. Clin Pharmacokinet. 2019. PMID: 29675639 Free PMC article. Review.

Cite

Share